Vaccine

For active immunisation of pigs from 18 days of age against enterotoxigenic F4positive and F18-positive Escherichia coli in order to reduce the incidence of moderate to severe post-weaning E. coli diarrhoea (PWD) in infected pigs reduce the faecal shedding of enterotoxigenic F4-positive and F18-positive E. coli from infected pigs. Onset of immunity: 7 days after vaccination Duration...

For the active immunisation of male and female pigs to reduce clinical signs (skin lesions and fever) of swine erysipelas caused by Erysipelothrix rhusiopathiae, serotype 1 and serotype 2. Onset of immunity is three weeks after completion of the basic vaccination scheme. Duration of immunity is six months.

A combined E. coli and C. perfringens Type B, C and D vaccine for pigs. For the passive protection of piglets by the active immunisation of breeding sows and gilts to prevent neonatal colibacillosis caused by K99 bearing strains of E. coli; to reduce neonatal colibacillosis caused by K88ab, K88ac and 987P bearing strains of E. coli and C. perfringens Type C necrotising infectious enteritis.

For active immunisation of pigs from 3 weeks of age to reduce lung lesions following infection with Mycoplasma hyopneumoniae. Onset of protection occurs by 2 weeks post vaccination and lasts for at least 26 weeks

Sheep For the active immunisation of sheep to: reduce clinical signs and mortality due to the toxin of Clostridium tetani (Tetanus); reduce mortality due to the epsilon toxin of Clostridium perfringens (Pulpy kidney); induce a serological response against the beta toxin of Clostridium perfringens (Struck, Lamb dysentery). The vaccine may be used in pregnant ewes to provide passive...

Reduction of neonatal enterotoxicosis of piglets, caused by E. coli strains, expressing the adhesins F4ab, F4ac, F4ad, F5, F6 and F41, during the first days of life

For the passive immunisation of progeny by active immunisation of sows and gilts to reduce mortality and clinical signs during the first days of life, caused by those E. coli strains, which express the adhesins F4ab (K88ab), F4ac (K88ac), F5 (K99) or F6 (987P) and caused by C. perfringens type C.

Short dated, expiry end of January 2023

For active immunisation of clinically healthy pigs in a PRRS virus contaminated environment, to reduce viraemia caused by infection with European strains of PRRS virus.

For active immunisation of breeding females from farms affected with European (genotype 1) Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) to reduce the duration of viraemia, the proportion of viraemic gilts/sows and viral loads in blood after exposure to PRRSV as shown under experimental conditions.

Piglets: For the passive protection of neonatal piglets by means of the active immunisation of breeding sows and gilts to reduce mortality and clinical signs of neonatal enterotoxicosis, such as diarrhoea caused by enterotoxigenic Escherichia coli, which express F4ab (K88ab), F4ac (K88ac), F5 (K99) or F6 (987P) adhesins. The persistence of these antibodies has not been established. For the passive...

For active immunisation of pigs from 3 weeks of age against porcine circovirus type 2 (PCV2) to reduce viral load in blood and lymphoid tissues and faecal shedding caused by infection with PCV2.

For the active immunisation of pigs of a minimum age of 21 days to reduce lung lesions that are caused by Mycoplasma hyopneumoniae. Onset of immunity: 4 weeks following vaccination. Duration of immunity: 6 months.

Breeding females: For active immunisation of breeding females from farms affected with European PRRS virus to reduce reproductive disorders, incidence and duration of viraemia, transplacental virus transmission, virus tissue load and clinical signs associated with infection with strains of PRRS virus. Under laboratory conditions, vaccination reduced the negative impact of PRRS virus infection on...